Category Archives: Transfeminine

Denmark population-wide study confirms association between cyproterone acetate and meningioma risk – and recent users of CPA are disproportionately trans women

Posted on August 1, 2021 by Zinnia Jones

Previously: Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women (June 2021) Disclaimer: I am not a medical professional and this is not medical advice. Since 2018, I’ve been covering emerging findings on … Continue reading →

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | Leave a comment

Three decades and hundreds of transfeminine breast augmentations show rare regret and trends toward larger implants

Posted on June 1, 2021 by Zinnia Jones

Trans women and transfeminine people seeking breast augmentation as part of medical transition face certain concerns distinct from cis women who may receive this surgery. Our anatomical baseline is very different from that of adult cis women, with a recent … Continue reading →

Posted in Breast, Oncology, Outcomes of transition, Surgery, Transfeminine, Transgender medicine | Tagged , | Leave a comment

Additional details on the connection between transgender HRT and migraine headache patterns

Posted on March 31, 2021 by Zinnia Jones

Previously: Migraine headaches, trans people, and hormone therapy (September 2018) More on the relationship between hormone therapy and migraine in trans people (December 2019) Disclaimer: I am not a medical professional and this is not medical advice. A migraine headache … Continue reading →

Posted in Biology of transition, Endocrinology, Trans youth, Transfeminine, Transgender medicine, Transmasculine | Tagged , , , | Leave a comment

Put it under your tongue? Typical hormone levels for trans women on HRT, and differing effects of oral and parenteral estradiol

Posted on January 31, 2021 by Zinnia Jones

Previously: Many trans men on HRT may not show testosterone levels in the “target range” – and that can be okay (November 2020) Last year, I covered the results of a study of trans men and transmasculine people who had … Continue reading →

Posted in Endocrinology, Outcomes of transition, Transfeminine | Tagged , , , | 1 Comment

Three-year study examines trans women’s breast development from feminizing HRT

Posted on November 30, 2020 by Zinnia Jones

For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of the most common points of concern – and uncertainty – is breast development. How soon will it start, how fast … Continue reading →

Posted in Breast, Endocrinology, Outcomes of transition, Progestogens, Transfeminine | Tagged , , | Leave a comment